Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Urinary Bladder Neoplasms: HELP
Ladan Fazli
Based on 12 articles published since 2008
||||
Expertise Level
The expertise of Ladan Fazli ranks in the Graphical view (beta)
Uncounted papers?
Work Locations
Details
Most likely:    University of British Columbia      
2017
  • H3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA. · H3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada, V5Z 1M9. · Vancouver Prostate Centre, Vancouver, BC, Canada, V6H 3Z6. · Eisai Inc., 4 Corporate Drive, Andover, MA, 01810, USA. · Department of Urology, University Hospital of Southampton, Hampshire, SO16 6YD, UK. · Department of Urology, University of Bern, Bern, CH-3010, Switzerland. · H3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA. · Pubmed 28740126
  • Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Urology, University of Bern, Bern, Switzerland. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. · Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark. · Zymeworks Inc., Vancouver, BC, Canada. · Vancouver Prostate Centre, Vancouver, BC, Canada. · Department of Urology, University Hospital of Southampton, Hampshire, UK. · Department of Medical Oncology, University Hospital of Southampton, Hampshire, UK. · Department of Urology, University of Bern, Bern, Switzerland. · GenomeDx Biosciences, Inc., Vancouver, BC, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Zymeworks Inc., Vancouver, BC, Canada. Electronic address: · Pubmed 28408175
2016
  • The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 26769750
2015
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia (TH, RS, HZO, WJ, IM, SA, TD, TT, NL, LF, PCB), Vancouver, British Columbia, Canada · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University (TH), Hiroshima, Japan. · Pubmed 26047983
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, Johannes Gutenberg University, Mainz, Germany. · Department of Cancer Endocrinology, BC Cancer Agency, Vancouver, BC, Canada. · Research and Development, GenomeDx Biosciences, Vancouver, BC, Canada. · Pubmed 26041878
2013
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 23555699
2012
  • University of British Columbia, Vancouver, BC V6T 1Z3, Canada. · Pubmed 22014457
2010
2009
  • The Prostate Centre at Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 19625496
2008
  • The Prostate Centre at Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 18316576
  • The Prostate Centre at Vancouver General Hospital, Department of Urologic Sciences, and Brain Research Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 18559493
  • The Prostate Centre at Vancouver General Hospital, Department of Urologic Sciences, Vancouver, BC, Canada. · Pubmed 18384625
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 12 total) written by Ladan Fazli about Urinary Bladder Neoplasms:

  • Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer. 2017
  • An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer. 2017
  • Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy. 2016
  • Targeting HER2 with T-DM1, an Antibody Cytotoxic Drug Conjugate, is Effective in HER2 Over Expressing Bladder Cancer. 2015
  • Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies. 2015
  • Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach. 2013
  • Tissue uptake of docetaxel loaded hydrophobically derivatized hyperbranched polyglycerols and their effects on the morphology of the bladder urothelium. 2012
  • Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death. 2010
  • Intravesical combination treatment with antisense oligonucleotides targeting heat shock protein-27 and HTI-286 as a novel strategy for high-grade bladder cancer. 2009
  • Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin. 2008
Show List of Full Article Records
Google Searches

Learn more about Ladan Fazli using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of British Columbia
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of British Columbia
2017
  • H3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA. · H3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada, V5Z 1M9. · Vancouver Prostate Centre, Vancouver, BC, Canada, V6H 3Z6. · Eisai Inc., 4 Corporate Drive, Andover, MA, 01810, USA. · Department of Urology, University Hospital of Southampton, Hampshire, SO16 6YD, UK. · Department of Urology, University of Bern, Bern, CH-3010, Switzerland. · H3 Biomedicine Inc., 300 Technology Square, Cambridge, MA, 02139, USA. · Pubmed 28740126
  • Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Urology, University of Bern, Bern, Switzerland. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada. · Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark. · Zymeworks Inc., Vancouver, BC, Canada. · Vancouver Prostate Centre, Vancouver, BC, Canada. · Department of Urology, University Hospital of Southampton, Hampshire, UK. · Department of Medical Oncology, University Hospital of Southampton, Hampshire, UK. · Department of Urology, University of Bern, Bern, Switzerland. · GenomeDx Biosciences, Inc., Vancouver, BC, Canada. · Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Zymeworks Inc., Vancouver, BC, Canada. Electronic address: · Pubmed 28408175
2016
  • The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan. · The Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada. Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 26769750
2015
  • Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia (TH, RS, HZO, WJ, IM, SA, TD, TT, NL, LF, PCB), Vancouver, British Columbia, Canada · Department of Urology, Institute of Biomedical and Health Science, Hiroshima University (TH), Hiroshima, Japan. · Pubmed 26047983
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Department of Urology, Johannes Gutenberg University, Mainz, Germany. · Department of Cancer Endocrinology, BC Cancer Agency, Vancouver, BC, Canada. · Research and Development, GenomeDx Biosciences, Vancouver, BC, Canada. · Pubmed 26041878
2013
  • The Vancouver Prostate Centre and Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. · Pubmed 23555699
2012
  • University of British Columbia, Vancouver, BC V6T 1Z3, Canada. · Pubmed 22014457
2010
2009
  • The Prostate Centre at Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 19625496
2008
  • The Prostate Centre at Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 18316576
  • The Prostate Centre at Vancouver General Hospital, Department of Urologic Sciences, and Brain Research Centre, University of British Columbia, Vancouver, British Columbia, Canada. · Pubmed 18559493
  • The Prostate Centre at Vancouver General Hospital, Department of Urologic Sciences, Vancouver, BC, Canada. · Pubmed 18384625
Yearly article counts 002120110113
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.